Filing Details

Accession Number:
0001628280-24-031188
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 17:27:36
Reporting Period:
2024-07-02
Accepted Time:
2024-07-03 17:27:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1935706 Tracie Oliver 177 E. Colorado Blvd
Suite 700
Pasadena CA 91105
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-02 9,394 $25.28 127,107 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. Partial disposition of RSUs to satisfy tax withholding obligations.
  3. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.